Molecular Tumor Board 2020-21
Offered By: University of Barcelona via Coursera
Course Description
Overview
Se trata de un curso que nace a raíz de una de las sesiones formativas que realiza cada 15 días el Servicio de Oncología Médica del Hospital Clínic de Barcelona (HCB). En este curso se presentan casos clínicos simulando un MTB de tumores sólidos, con un objetivo principal, mejorar el conocimiento específico del impacto clínico del perfil molecular en tumores sólidos.
Está destinado a médicos oncólogos y a estudiantes y profesionales vinculados a la oncología médica. Cada seminario que conforma el curso lo presenta un profesional de una patología diferente del Servicio de Oncología Médica del HCB.
Syllabus
- GERMLIME - Breaking myths. Is lung cancer a hereditary disease?
- MESO - How can a typical EGFR+ case, became atypical
- BREAST - Is there any role for precision medicine in triple negative breast cancer?
- URO-MESO - Clinical and Mutational Lanscape of Lethal Castrate Resistant prostate Cancer
- LUNG - Off-label treatments really work?
- PANCREAS - Precision medicine, is not only about somatic
- COLON - Why doesn't immunotherapy work for everyone?
- UPPER GI - Screening molecular in orphan tumors
- BREAST - Beyond actionable mutations
Taught by
Dra. Laura Mezquita Perez and Dr. Aleix Prat Aparicio
Tags
Related Courses
Molecular Tumor Board 2021-22University of Barcelona via Coursera Molecular Tumor Board
University of Barcelona via Coursera Modelling Hypoxia-Driven Cell Reprogramming in Solid Tumours
Fields Institute via YouTube Cancer's Faustian Bargain: Exploiting Whole Genome Doubling in Solid Tumors
Stanford Department of Medicine via YouTube Cytokine Armored CAR NK Cell Therapy for Advanced Ovarian Cancer
Labroots via YouTube